Sign Out
There is no information on overdosage with Pembrolizumab (KEYTRUDA). The maximum tolerated dose of Pembrolizumab (KEYTRUDA) has not been determined. In clinical trials, patients received up to 10 mg/kg with a similar safety profile to that seen in patients receiving 2 mg/kg.
In case of overdose, patients must be closely monitored for signs or symptoms of adverse reactions, and appropriate symptomatic treatment instituted.
